High Mark Wealth Management LLC Pliant Therapeutics, Inc. Transaction History
High Mark Wealth Management LLC
- $173 Million
- Q4 2024
A detailed history of High Mark Wealth Management LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, High Mark Wealth Management LLC holds 75,000 shares of PLRX stock, worth $246,750. This represents 0.57% of its overall portfolio holdings.
Number of Shares
75,000
Previous 67,500
11.11%
Holding current value
$246,750
Previous $756,000
30.56%
% of portfolio
0.57%
Previous 0.42%
Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
173Shares Held
62.5MCall Options Held
215KPut Options Held
343K-
Deep Track Capital, LP Greenwich, CT5.97MShares$19.6 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$16.4 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$15.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$10.6 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.2MShares$10.5 Million2.34% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $160M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...